Akili, Inc. (AKLI)

0,4173 -0,0033 (-0,78%) Ab 12:46PM EDT. Markt geöffnet.

Akili, Inc.

No. 312, 71 Commercial Street
Boston, MA 02109
United States
617 313 8853
https://www.akiliinteractive.com

Sektor(en): Healthcare
Branche: Health Information Services
Vollzeitmitarbeiter: 68

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Walter Edward Martucci II, Ph.D.	Co-Founder & Chairman	759,1k	N/A	1983
Mr. Matthew Franklin M.B.A.	President, CEO & Director	639,13k	N/A	1974
Dr. Adam Gazzaley M.D., Ph.D.	Co-Founder, Chief Science Advisor & Director	126,45k	N/A	1970
Ms. Jacqueline L. Studer J.D.	Chief Legal Officer, General Counsel & Secretary	559,55k	N/A	1959
Ms. Caty Reid	VP of Marketing & Communications	N/A	N/A	N/A
Dr. Scott H. Kollins Ph.D.	Chief Medical Officer	N/A	N/A	N/A
Mr. Jonathan David	Chief Product Officer	N/A	N/A	1978

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It also offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. The company was founded in 2011 and is headquartered in Boston, Massachusetts.

Corporate Governance

Akili, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.